Novartis Ag (NVS) Enterprise Value (2009 - 2025)
Novartis Ag recorded quarterly Enterprise Value of -$2.3 billion in Q4 2025, down 635.07% quarter-over-quarter from $422.0 million in Q3 2025, and down 4.54% year-over-year from -$2.4 billion in Q4 2024.
Novartis Ag's Enterprise Value history runs 17 years deep, the most recent figure standing at -$2.3 billion for Q4 2025.
- In Q4 2025, Enterprise Value fell 4.54% year-over-year to -$2.3 billion; the TTM figure through Dec 2025 stood at -$2.3 billion (down 4.54% YoY), while the FY2025 annual figure was -$2.3 billion, down 4.54% from the prior year.
- Enterprise Value came in at -$2.3 billion for Q4 2025 at Novartis Ag, down from $422.0 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of $422.0 million in Q3 2025 to a low of -$28.2 billion in Q4 2021.
- A 5-year average of -$5.3 billion and a median of -$2.2 billion in 2024 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value jumped 2700.0% in 2021 and sank 6340.0% in 2023, its largest moves.
- Novartis Ag's Enterprise Value stood at -$28.2 billion in 2021, then soared by 33.07% to -$18.8 billion in 2022, then advanced by 23.9% to -$14.3 billion in 2023, then soared by 84.94% to -$2.2 billion in 2024, then retreated by 4.54% to -$2.3 billion in 2025.
- According to Business Quant data, Enterprise Value over the past three periods registered -$2.3 billion, $422.0 million, and -$6.7 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | -5.28 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | -22.05 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | -9.35 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -5.65 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | -12.04 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | -7.73 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | -12.77 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | -10.45 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | -4.68 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.26 Bn |
| Sep 30, 2025 | 422.00 Mn |
| Jun 30, 2025 | -6.67 Bn |
| Mar 31, 2025 | 3.00 Mn |
| Dec 31, 2024 | -2.16 Bn |
| Sep 30, 2024 | -240.00 Mn |
| Jun 30, 2024 | -7.90 Bn |
| Dec 31, 2023 | -14.35 Bn |
| Sep 30, 2023 | -644.00 Mn |
| Jun 30, 2023 | -11.92 Bn |
| Mar 31, 2023 | 1.00 Mn |
| Dec 31, 2022 | -18.85 Bn |
| Sep 30, 2022 | -10.00 Mn |
| Jun 30, 2022 | -3.54 Bn |
| Mar 31, 2022 | -73.00 Mn |
| Dec 31, 2021 | -28.16 Bn |
| Sep 30, 2021 | 156.00 Mn |
| Jun 30, 2021 | -5.03 Bn |
| Mar 31, 2021 | -6.00 Mn |
| Dec 31, 2020 | -11.56 Bn |
| Sep 30, 2020 | -6.00 Mn |
| Jun 30, 2020 | -5.91 Bn |
| Mar 31, 2020 | -79.00 Mn |
| Dec 31, 2019 | -11.10 Bn |
| Sep 30, 2019 | 74.00 Mn |
| Jun 30, 2019 | -13.19 Bn |
| Mar 31, 2019 | -421.00 Mn |
| Dec 31, 2018 | -15.28 Bn |
| Sep 30, 2018 | 81.00 Mn |
| Jun 30, 2018 | -8.77 Bn |
| Mar 31, 2018 | 3.00 Mn |
| Dec 31, 2017 | -9.49 Bn |
| Sep 30, 2017 | 199.00 Mn |
| Jun 30, 2017 | -7.36 Bn |
| Mar 31, 2017 | 111.00 Mn |
| Dec 31, 2016 | -7.26 Bn |
| Sep 30, 2016 | 159.00 Mn |
| Jun 30, 2016 | 94.00 Bn |
| Mar 31, 2016 | 192.00 Bn |
| Dec 31, 2015 | -4.81 Bn |
| Sep 30, 2015 | -131.99 Bn |
| Jun 30, 2015 | 2.00 |
| Mar 31, 2015 | 68.00 |
| Dec 31, 2014 | -355.93 Bn |
| Sep 30, 2014 | 74.00 |
| Jun 30, 2014 | 30.00 |
| Mar 31, 2014 | 27.00 |
| Dec 31, 2013 | 117.00 |
| Sep 30, 2013 | 132.00 |
| Jun 30, 2013 | 135.00 |
| Mar 31, 2013 | 119.00 |
| Sep 30, 2012 | 123.00 |
| Jun 30, 2012 | 111.00 |
| Mar 31, 2012 | 22.00 |
| Dec 31, 2011 | 96.00 |
| Sep 30, 2011 | 97.00 |
| Jun 30, 2011 | 22.00 |
| Mar 31, 2011 | 51.00 |
| Dec 31, 2010 | 175.00 |
| Sep 30, 2010 | 79.00 |
| Jun 30, 2010 | 20.00 |
| Mar 31, 2010 | 15.00 |
| Dec 31, 2009 | -2.89 Bn |
| Sep 30, 2009 | 36.00 |
| Jun 30, 2009 | 9.00 |
| Mar 31, 2009 | 13.00 |